Chromobacterium violaceum infection.
Chromobacterium violaceum infection is confined to the tropical and subtropical areas, with almost all reported cases occurring in the Southeast. The most common feature of this infection is sepsis, followed by cutaneous involvement and liver abscesses. Treatment consists of surgical drainage of purulent collections and appropriate antimicrobial therapy, such as chloramphenicol, gentamicin, imipenem, trimethoprim-sulfamethoxazole, or ciprofloxacin. Although C violaceum infection is rare, it is potentially fatal and remains an important entity for clinicians to suspect and treat appropriately.
Midani
S
S
Department of Pediatrics, Nemours Children's Clinic, Jacksonville, University of Florida Health Science Center, 32207, USA.
Rathore
M
M
D000900:Anti-Bacterial Agents; D002648:Child; D002861:Chromobacterium / Q000472:pathogenicity; D004322:Drainage; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D016905:Gram-Negative Bacterial Infections / Q000175:diagnosis* / Q000188:drug therapy; D006801:Humans; D008100:Liver Abscess / Q000175:diagnosis* / Q000188:drug therapy; D008111:Liver Function Tests; D008297:Male; D008826:Microbial Sensitivity Tests; D014057:Tomography, X-Ray Computed
D000900:Anti-Bacterial Agents